MAP3K1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.16960000024125E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.86428999999766E-05 |
Normal-vs-Stage2 |
8.202500E-04 |
Normal-vs-Stage3 |
1.36329999511631E-08 |
Normal-vs-Stage4 |
2.36410000464815E-08 |
Stage1-vs-Stage2 |
9.140800E-01 |
Stage1-vs-Stage3 |
1.897770E-03 |
Stage1-vs-Stage4 |
3.019200E-03 |
Stage2-vs-Stage3 |
1.213790E-01 |
Stage2-vs-Stage4 |
9.938400E-02 |
Stage3-vs-Stage4 |
7.575800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.94110000020886E-07 |
Normal-vs-AfricanAmerican |
2.03639999996064E-06 |
Normal-vs-Asian |
7.092600E-01 |
Caucasian-vs-AfricanAmerican |
7.629000E-01 |
Caucasian-vs-Asian |
2.367600E-01 |
AfricanAmerican-vs-Asian |
2.212000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.00029999961349E-07 |
Normal-vs-Female |
4.25149999982999E-07 |
Male-vs-Female |
8.577800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.478050E-02 |
Normal-vs-Age(41-60Yrs) |
3.35179999999546E-06 |
Normal-vs-Age(61-80Yrs) |
9.35259999446103E-08 |
Normal-vs-Age(81-100Yrs) |
3.38399999999517E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.288200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.978230E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.375180E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.109040E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.621190E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.841600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.555100E-03 |
Normal-vs-Grade 2 |
5.84399999999929E-05 |
Normal-vs-Grade 3 |
1.51630000000402E-07 |
Normal-vs-Grade 4 |
7.72889974243185E-10 |
Grade 1-vs-Grade 2 |
7.548800E-01 |
Grade 1-vs-Grade 3 |
2.380200E-01 |
Grade 1-vs-Grade 4 |
2.508200E-02 |
Grade 2-vs-Grade 3 |
1.893950E-02 |
Grade 2-vs-Grade 4 |
1.388090E-04 |
Grade 3-vs-Grade 4 |
7.559500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.95010000000929E-05 |
Normal-vs-ccB subtype |
1.07049999975573E-07 |
ccA subtype-vs-ccB subtype |
6.676800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.41759999978164E-07 |
Normal-vs-N1 |
1.137360E-01 |
N0-vs-N1 |
4.183400E-01 |
|
|